The query was composed of both mutations and CNAs molecular profiles covering all the available cancer studies with the user defined gene list as GLS, CAD, GFPT1, PPAT, CPS1, GLUL, GLUD1, GLUD2, GGT1, GAD1, and GAD2. This evidence concerns the gene GAD2 and cancer.